Related Experiment Video
Updated: Jun 22, 2026
Extrahepatic Bile Duct and Gall Bladder Dissection in Nine-Day-Old Mouse Neonates
Published on: August 23, 2022
Biliary atresia
Giorgina Mieli-Vergani1, Diego Vergani
1Paediatric Liver Centre, Institute of Liver Studies, King's College London School of Medicine, King's College Hospital, Denmark Hill, London, SE5 9RS, UK. giorgina.vergani@kcl.ac.uk
Insights
Biliary atresia (BA) is a serious infant liver disease. Early surgery offers a 90% survival rate for infants diagnosed with conjugated hyperbilirubinaemia.
Area of Science:
- Pediatric Gastroenterology
- Hepatology
- Neonatology
Background:
- Biliary atresia (BA) is an infant liver disease caused by bile duct inflammation.
- It's the most common surgically correctable liver disorder in infants and a leading reason for pediatric liver transplants.
- Early symptoms include conjugated hyperbilirubinaemia, with other signs appearing later.
Purpose of the Study:
- To review the key aspects of biliary atresia.
- To highlight the importance of early diagnosis and surgical intervention.
- To discuss potential causes including infectious, genetic, and immunologic factors.
Main Methods:
- This is a review article.
- It synthesizes current knowledge on biliary atresia.
- Evidence regarding infectious, genetic, and immunologic mechanisms is discussed.
Main Results:
- Early diagnosis of conjugated hyperbilirubinaemia is crucial.
- Surgical success is highly dependent on the age of intervention.
- With timely surgery and potential transplantation, survival rates approach 90%.
Conclusions:
- Biliary atresia requires urgent referral for infants with conjugated hyperbilirubinaemia.
- Prompt surgical treatment significantly improves outcomes.
- The etiology remains multifactorial, involving infectious, genetic, and immune pathways.
Abstract:
Biliary atresia (BA) is a condition unique to infancy. It results from inflammatory destruction of the intrahepatic and extrahepatic bile ducts. It is the most frequent surgically correctable liver disorder in infancy and the most frequent indication for liver transplantation in paediatric age. Clinical presentation is in the first few weeks of life with conjugated hyperbilirubinaemia (dark urine and pale stools); other manifestations of liver disease, such as failure to thrive, splenomegaly and ascites, appear only later, when surgery is unlikely to be successful. Hence, all infants with conjugated hyperbilirubinaemia must be urgently referred to specialised centres for appropriate treatment. Success of surgery depends on the age at which it is performed. With corrective surgery, followed, when necessary, by liver transplantation, the overall survival rate is approximately 90%. The cause of BA is unknown, but there is evidence for the involvement of infectious, genetic and immunologic mechanisms, which will be discussed in this review.
